Multimodal Treatments for Brain Metastases from Renal Cell Carcinoma: Results of a Multicentric Retrospective Study

SIMPLE SUMMARY: Around 2–15% of primary renal cell carcinoma patients (RCC) will develop brain metastases (BMs) during the disease course. The prognosis of brain metastatic RCC patients is poor when compared with extracranial metastatic patients, and determining the optimal local therapeutic approac...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarria, Pierina, Pessina, Federico, Minniti, Giuseppe, Franzese, Ciro, Marini, Beatrice, D’agostino, Giuseppe, Badalamenti, Marco, Raspagliesi, Luca, Reggiori, Giacomo, Lobefalo, Francesca, Fariselli, Laura, Franceschini, Davide, Bellu, Luisa, Clerici, Elena, Pinzi, Valentina, Scorsetti, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000216/
https://www.ncbi.nlm.nih.gov/pubmed/36900186
http://dx.doi.org/10.3390/cancers15051393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000216/
https://www.ncbi.nlm.nih.gov/pubmed/36900186
http://dx.doi.org/10.3390/cancers15051393

Ejemplares similares